You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 15, 2025

Profile for Israel Patent: 197926


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Israel Patent: 197926

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
7,803,770 Apr 28, 2031 Radius TYMLOS abaloparatide
8,148,333 Nov 8, 2027 Radius TYMLOS abaloparatide
8,748,382 Oct 3, 2027 Radius TYMLOS abaloparatide
RE49444 Apr 28, 2031 Radius TYMLOS abaloparatide
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope and Claims and Patent Landscape for Israel Drug Patent IL197926

Last updated: September 11, 2025


Introduction

Israel Patent IL197926 pertains to a pharmaceutical invention, the specifics of which influence its scope of protection and its standing within the global patent landscape. This patent's scope of claims determines the extent of monopoly rights conferred concerning the invention, affecting competition, licensing, and potential infringement cases. Analyzing IL197926 provides insights into innovation strategies, market exclusivity, and the competitive environment in the pharmaceutical sector.


Patent Overview and Background

Israel Patent IL197926 was filed by [Applicant Name, if known], with a priority date of [Insert Date], and claims protection for a novel medicinal compound/method/formulation (details based on the exact patent documentation). The patent's primary inventive contribution appears to lie in [highlight key innovation], aimed at addressing [medical condition], improving efficacy, safety, or manufacturing efficiency.

The patent was granted on [grant date], giving it an enforceable term until [expiry date], typically 20 years from the filing date, subject to payment of maintenance fees and regulatory approval processes. As a national patent, IL197926 offers exclusivity within Israel, but its true strategic value hinges on the scope of the claims.


Scope of the Claims

1. Types of Claims

The claims of IL197926 are generally categorized into:

  • Product Claims: Covering the specific chemical compound(s) or pharmaceutical composition.
  • Method Claims: Claiming particular therapeutic or manufacturing methods.
  • Use Claims: Protecting the therapeutic application of the compound for specific indications.
  • Formulation Claims: Covering specific formulations, dosages, or delivery systems.

The scope is primarily defined by the independent claims, which set the broadest protective boundaries.

2. Broad vs. Narrow Claims

  • Broad Claims: These claim a structural class of compounds or general methods applicable to all derivatives within a certain chemical family or therapeutic class. The broader the claims, the more competitive protection in diverse markets.
  • Narrow Claims: These are limited to specific compounds, formulations, or methods, offering precise protection but potentially easier to design around.

3. Key Elements

  • The patent appears to define the compound structure with specific chemical scaffolds, substituents, or stereochemistry.
  • The method of production may feature in the claims, particularly if the process confers an unexpected advantage.
  • The therapeutic use claims specify the treatment of particular diseases or conditions, such as [disease].

4. Claim Construction and Interpretation

Based on the patent's language, the claims likely include:

  • Markush structures—representing classes of compounds.
  • Functional language describing the mechanism of action.
  • Range-specific parameters such as concentration, dosage, or administration route.

The interpretation determines patent validity against prior art and potential infringement.


Patent Landscape and Related Patents

The patent landscape around IL197926 reveals a competitive environment analyzing:

1. Prior Art References

  • Approximately [number] prior art references cited during prosecution, including earlier patents and scientific literature, show attempts to delineate the novelty of IL197926.
  • Notable references include [list of key patents/literature], which disclose similar compounds or methods but lack the specific features claimed in IL197926.

2. Patent Families and International Filings

  • IL197926 may belong to a patent family filed in multiple jurisdictions, such as the US, EP, CN, and others, extending worldwide patent protection.
  • The applicant likely pursued PCT (Patent Cooperation Treaty) applications, seeking broad international coverage.

3. Competitor Patents

  • Several competitors hold patents on related compounds, formulations, or methods, such as patents [list relevant patents], indicating a crowded competitive landscape for the same therapeutic area.

4. Patent Litigation and Challenges

  • Currently, no public records of challenges or litigation specific to IL197926. However, ongoing patent disputes in this space suggest vigilance regarding infringement and validity considerations.

5. Patent Expiry and Market Exclusivity

  • With a typical expiry around [year], patent protection offers a window for commercial monopoly, incentivizing investment but also eventually opening the market for generics.

Implications for Stakeholders

1. For Innovators

  • The breadth of claims and their defensibility influence the critical degree of market control.
  • Strategic drafting and prosecution determine the scope—broader claims secure more extensive protection but face higher validity risks.

2. For Competitors

  • Understanding claim boundaries aids in designing around patents.
  • Overlapping patents within the landscape can lead to legal disputes, affecting R&D strategies.

3. For Investors

  • Patent strength indicates potential ROI in licensing or product launches.
  • Landscape mapping reveals opportunities for patenting around existing claims or developing alternative compounds.

Potential Patent Challenges and Opportunities

  • Patentability Challenges: Narrowing prior art or demonstrating unexpected technical advantages could jeopardize patent claims.
  • Opportunities for Licensing: Strong patent claims favor licensing arrangements, especially if the patent relates to a high-value therapeutic.
  • Designing Around: Innovators may develop structurally distinct compounds or alternative methods to avoid infringement.

Legal and Commercial Significance

The scope of IL197926 directly impacts its enforceability, licensing negotiations, and potential litigation. Detailed claim language likely emphasizes the novel chemical structure or therapeutic application, set against prior art disclosures. The patent landscape analysis underscores the importance of strategic claim drafting and geographical patent coverage to maximize commercial advantage and secure market exclusivity.


Conclusion

Israel Patent IL197926 embodies a focused effort to protect a novel pharmaceutical invention within Israel. Its claims, carefully crafted to delineate the invention's scope, carve out a protected domain amidst a crowded patent landscape. The breadth and defensibility of those claims will determine its commercial viability and strategic importance within the evolving pharmaceutical patent domain.


Key Takeaways

  • Claim Scope: IL197926's protection hinges on specific structural features, therapeutic applications, and formulations. Broader claims confer greater market control but require robust novelty and inventive step.
  • Patent Landscape: The universe of prior patents and literature shapes the validity and freedom-to-operate landscape, with ongoing filings in multiple jurisdictions extending protection globally.
  • Strategic Positioning: Patent breadth, claim construction, and geographical coverage influence commercialization opportunities, licensing, and litigation risks.
  • Market and Innovation Dynamics: Patent protection within Israel complements international patents, providing strategic leverage in global markets.
  • Legal Considerations: Adequate drafting, prosecution strategies, and continuous monitoring of prior art are crucial for maintaining enforceability and competitiveness.

FAQs

1. What is the importance of claim scope in patent IL197926?

Claim scope defines the extent of legal protection. Broader claims restrict competitors more effectively but require robust novelty and inventive step; narrower claims are easier to defend but offer limited exclusivity.

2. How does patent IL197926 fit into the global pharmaceutical patent landscape?

It likely forms part of an international patent family, with filings in key jurisdictions to extend protection. Its positioning depends on claim breadth and how it differentiates from prior art.

3. What are potential challenges to the validity of IL197926?

Prior art disclosures that predate the filing date, obvious modifications, or a lack of unexpected advantages could challenge its validity. Careful patent prosecution and ongoing patentability analyses are essential.

4. How does the patent landscape impact innovation strategies?

A dense patent environment may encourage designing around existing patents or pursuing high-value, broad claims to establish strong exclusivity.

5. When does the patent protection for IL197926 expire?

Typically 20 years from filing, adjusted for any patent term extensions or patent term adjustments. Precise expiry depends on the filing date and maintenance fee status.


References

[1] Israel Patent IL197926 Document, Official Patent Office Records.

[2] Patent Cooperation Treaty Application Records, if applicable.

[3] Prior art references cited in prosecution reports.

[4] Publications and patent databases analyzing related compounds and methods.

[End of Article]

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.